Physician profile
Mary E Steward
NPI 1235109646
$1,873.72
in general payments reported to CMS, 2019-2025
13 companies · $246 in 2025
The $246 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $224 · 2022: $167 · 2023: $829 · 2024: $408 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,418 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,418.04 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $309.84 | 2022-2024 | Freestyle Libre 3 |
| Acadia Pharmaceuticals INC | $269.30 | 2023 | Nuplazid |
| Takeda Pharmaceuticals U.S.A., INC. | $219.95 | 2021-2025 | |
| Novo Nordisk INC | $164.04 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $148.90 | 2022-2023 | Andexxa |
| Insulet Corporation | $146.69 | 2024 | Omnipod |
| Xeris Pharmaceuticals, INC. | $123.83 | 2025 | Gvoke Hypopen |
| Dexcom, INC. | $116.70 | 2023 | Dexcom G7 Gss (161) |
| Axsome Therapeutics, INC. | $115.25 | 2023 | Sunosi |
| Lilly USA, LLC | $113.18 | 2023 | Jardiance |
| Sage Therapeutics, LLC | $99.62 | 2023 | |
| Sk Life Science, INC. | $26.50 | 2021 | |
| Janssen Pharmaceuticals, INC | $19.92 | 2023 | Spravato |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Steward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.